NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

15 hedge funds and large institutions have $603K invested in Northwest Biotherapeutics, Inc. Common stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$32.3K
2
+$6K
3
+$3K
4
BCWM
Bartlett & Co Wealth Management
Ohio
+$2.99K

Top Sellers

1
-$13.6K
2
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$262K
2
$194K
3
$31K
4
$27K
5
$18K
6
$15K
7
$14K
8
$10K
9
$9K
10
$6.97K
11
$6K
12
$4K
13
$3K
14
$2.99K
15
–